Dongsung Pharmaceutical Decides Capital Reduction Under Rehabilitation Plan, Delays Schedule
- Decided to cancel 250,000 common shares held by a specific shareholder (Lee) without compensation as part of court-approved rehabilitation plan
- Existing cancellation date (May 14, 2026) postponed; new schedule to be announced later
- New stock listing date undetermined; will be re-disclosed when fixed
- Plans to sequentially issue convertible bonds and corporate bonds with court approval
- Board resolution date is the date of court approval for change in effective date of capital reduction
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: [Correction of Description] Report on Major Matters (Decision on Capital Reduction)
- Company: Dongsung Pharmaceutical (002210)
- Submission: Dongsung Pharmaceutical Co., Ltd.
- Receipt: 05-14-2026